ZC 79 Pill - white round, 6mm
Pill with imprint ZC 79 is White, Round and has been identified as Lamotrigine 25 mg. It is supplied by Zydus Pharmaceuticals.
Lamotrigine is used in the treatment of Bipolar Disorder; Epilepsy; Lennox-Gastaut Syndrome; Seizure Prevention; Seizures and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ZC 79



Lamotrigine
- Imprint
- ZC 79
- Strength
- 25 mg
- Color
- White
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals
- Inactive Ingredients
-
lactose monohydrate,
magnesium stearate,
sodium starch glycolate type A potato,
povidone,
microcrystalline cellulose
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
63739-0670 (Discontinued) | McKesson Packaging Services |
68084-0318 | Amerisource Health Services |
68382-0006 | Zydus Pharmaceuticals (USA) Inc. |
54868-6078 | Physicians Total Care Inc. (repackager) |
More about lamotrigine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,841)
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: triazine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Lamotrigine drug information
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Extended-Release Tablets
- Lamotrigine Orally Disintegrating Tablets
Other brands
Lamictal, Lamictal XR, Lamictal ODT, Subvenite, Lamictal CD
Professional resources
- Lamotrigine monograph
- Lamotrigine (FDA)
- Lamotrigine Chewable Tablet (FDA)
- Lamotrigine Extended Release Tablet (FDA)
- Lamotrigine ODT (FDA)
- Lamotrigine Tablets (FDA)
Other brands
Lamictal, Lamictal XR, Subvenite
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.